• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于国际专家小组调查的钇-90 树脂微球肝手术后放射栓塞治疗推荐建议。

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.

机构信息

Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Eur Radiol. 2017 Dec;27(12):4923-4930. doi: 10.1007/s00330-017-4889-6. Epub 2017 Jul 3.

DOI:10.1007/s00330-017-4889-6
PMID:28674968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5674129/
Abstract

INTRODUCTION

Guidelines on how to adjust activity in patients with a history of liver surgery who are undergoing yttrium-90 radioembolisation (Y-RE) are lacking. The aim was to study the variability in activity prescription in these patients, between centres with extensive experience using resin microspheres Y-RE, and to draw recommendations on activity prescription based on an expert consensus.

METHODS

The variability in activity prescription between centres was investigated by a survey of international experts in the field of Y-RE. Six representative post-surgical patients (i.e. comparable activity prescription, different outcome) were selected. Information on patients' disease characteristics and data needed for activity calculation was presented to the expert panel. Reported was the used method for activity prescription and whether, how and why activity reduction was found indicated.

RESULTS

Ten experts took part in the survey. Recommendations on activity reduction were highly variable between the expert panel. The median intra-patient range was 44 Gy (range 18-55 Gy). Reductions in prescribed activity were recommended in 68% of the cases. In consensus, a maximum D of 50 Gy was recommended.

CONCLUSION

With a current lack of guidelines, large variability in activity prescription in post-surgical patients undergoing Y-RE exists. In consensus, D ≤50 Gy is recommended.

KEY POINTS

• BSA method does not account for a decreased remnant liver volume after surgery. • In post-surgical patients, a volume-based activity determination method is recommended. • In post-surgical patients, a mean D of ≤ 50Gy should be aimed for.

摘要

简介

对于接受钇-90 放射性栓塞治疗(Y-RE)的有肝手术史患者,如何调整活动量的指南尚缺乏。本研究旨在研究在使用树脂微球 Y-RE 方面经验丰富的中心之间,这些患者的活动量处方的差异,并根据专家共识提出活动量处方的建议。

方法

通过对 Y-RE 领域的国际专家进行调查,研究了中心之间的活动量处方差异。选择了 6 名具有代表性的术后患者(即可比较的活动量处方,不同的结果)。向专家小组提供了患者疾病特征和活动计算所需的数据信息。报告了使用的活动量处方方法,以及是否、如何以及为何发现需要减少活动量。

结果

10 名专家参与了调查。专家小组对减少活动量的建议差异很大。患者内的中位数范围为 44Gy(范围 18-55Gy)。建议减少 68%的病例的处方活动量。专家一致推荐最大 D 值为 50Gy。

结论

由于目前缺乏指南,接受 Y-RE 的肝手术后患者的活动量处方存在很大差异。专家一致建议 D 值≤50Gy。

关键点

• BSA 方法没有考虑到手术后剩余肝体积的减少。

• 对于肝手术后患者,建议使用基于体积的活动量确定方法。

• 对于肝手术后患者,应将平均 D 值目标设定为 ≤50Gy。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c516/5674129/0b0855d41857/330_2017_4889_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c516/5674129/6b260c83a036/330_2017_4889_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c516/5674129/0b0855d41857/330_2017_4889_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c516/5674129/6b260c83a036/330_2017_4889_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c516/5674129/0b0855d41857/330_2017_4889_Fig2_HTML.jpg

相似文献

1
Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.基于国际专家小组调查的钇-90 树脂微球肝手术后放射栓塞治疗推荐建议。
Eur Radiol. 2017 Dec;27(12):4923-4930. doi: 10.1007/s00330-017-4889-6. Epub 2017 Jul 3.
2
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.国际推荐使用钇-90 树脂微球行原发性和转移性肝脏疾病的个性化选择性内放射治疗。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1570-1584. doi: 10.1007/s00259-020-05163-5. Epub 2021 Jan 12.
3
Dose-response for yttrium-90 resin microsphere radioembolisation.钇-90 树脂微球放射性栓塞的剂量反应。
Nucl Med Commun. 2021 Mar 1;42(3):345-347. doi: 10.1097/MNM.0000000000001351.
4
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.使用MIRD剂量测定法和树脂微球进行钇-90放射性栓塞治疗。
Eur Radiol. 2021 Mar;31(3):1316-1324. doi: 10.1007/s00330-020-07231-8. Epub 2020 Sep 8.
5
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.不可切除肝细胞癌的治疗选择,重点是使用钇-90树脂微球的选择性内放射治疗(SIRT)
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30.
6
High quality imaging and dosimetry for yttrium-90 (Y) liver radioembolization using a SiPM-based PET/CT scanner.使用基于硅光电倍增管的 PET/CT 扫描仪进行钇-90(Y)肝脏放射栓塞的高质量成像和剂量测定。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2426-2436. doi: 10.1007/s00259-021-05188-4. Epub 2021 Jan 14.
7
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.多模态成像可以预测不可切除的结直肠癌肝转移灶对钇-90标记树脂微球放射性栓塞治疗的代谢反应。
Phys Med Biol. 2008 Nov 21;53(22):6591-603. doi: 10.1088/0031-9155/53/22/019. Epub 2008 Oct 31.
8
Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.钇-90微球放射性栓塞术:一种治疗不可切除肝转移瘤的有效治疗方式。
J Med Imaging Radiat Oncol. 2013 Feb;57(1):72-80. doi: 10.1111/j.1754-9485.2012.02459.x. Epub 2012 Oct 9.
9
Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.钇-90 树脂微球选择性内放射治疗的患者选择和活动计划指南。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):401-7. doi: 10.1016/j.ijrobp.2010.08.015. Epub 2010 Oct 13.
10
Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Comparative Study of the Effectiveness, Safety, and Dosimetry of Glass-Based versus Resin-Based Microspheres.钇-90 放射性微球肝脏肿瘤切除术:玻璃微球与树脂微球在疗效、安全性和剂量学方面的对比研究。
J Vasc Interv Radiol. 2023 Jul;34(7):1226-1234. doi: 10.1016/j.jvir.2023.02.030. Epub 2023 Mar 21.

引用本文的文献

1
Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry.放射性栓塞术后6个月持续性肝功能毒性的发生率及危险因素:非可切除性肝肿瘤放射性微球(RESIN)注册研究分析
J Gastrointest Oncol. 2021 Apr;12(2):639-657. doi: 10.21037/jgo-20-346.
2
The physics of radioembolization.放射性栓塞的物理学
EJNMMI Phys. 2018 Nov 2;5(1):22. doi: 10.1186/s40658-018-0221-z.

本文引用的文献

1
Origin, dosimetric effect and clinical limitations of the semi-empirical body surface area method for radioembolisation using yttrium-90 resin microspheres.使用钇-90树脂微球进行放射性栓塞的半经验体表面积法的起源、剂量学效应及临床局限性
J Med Imaging Radiat Oncol. 2016 Jun;60(3):382-5. doi: 10.1111/1754-9485.12449. Epub 2016 Mar 28.
2
Radioembolization following Liver Resection: Safety and Dosing Considerations.肝切除术后放射性栓塞:安全性及剂量考量
J Vasc Interv Radiol. 2016 Jan;27(1):46-51. doi: 10.1016/j.jvir.2015.09.017. Epub 2015 Nov 6.
3
Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model.
使用体表面积法的钇-90标记树脂微球放射性栓塞术中肝内活性分布——一个不太完美的模型
J Vasc Interv Radiol. 2015 Nov;26(11):1615-21. doi: 10.1016/j.jvir.2015.07.021. Epub 2015 Aug 28.
4
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.从放射生物学和剂量学角度看肝脏病变的放射性栓塞治疗。
Front Oncol. 2014 Aug 19;4:210. doi: 10.3389/fonc.2014.00210. eCollection 2014.
5
No infectious hepatic complications following radioembolization with 90Y microspheres in patients with biliodigestive anastomosis.放射性栓塞治疗伴胆肠吻合术后患者使用 90Y 微球后无肝感染性并发症。
Anticancer Res. 2014 Aug;34(8):4315-21.
6
Radioembolization of hepatic tumors.肝肿瘤的放射性栓塞治疗。
J Gastrointest Oncol. 2014 Jun;5(3):178-89. doi: 10.3978/j.issn.2078-6891.2014.037.
7
Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.基于体表面积的活动计算在结直肠癌肝转移放射性栓塞中的局限性。
J Vasc Interv Radiol. 2014 Jul;25(7):1085-93. doi: 10.1016/j.jvir.2013.11.018. Epub 2014 Jan 21.
8
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.基于 99mTc-聚合白蛋白-99mTc-硫胶体 SPECT 融合的 90Y 放射性栓塞治疗剂量预测效用。
J Nucl Med. 2013 Dec;54(12):2055-61. doi: 10.2967/jnumed.113.123257. Epub 2013 Oct 21.
9
Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.既往肝切除术对钇-90微球放射性栓塞治疗不可切除性肝肿瘤患者的安全性和疗效的影响。
Am J Clin Oncol. 2014 Oct;37(5):454-60. doi: 10.1097/COC.0b013e31827deea1.
10
Prognostic factors and prevention of radioembolization-induced liver disease.放射性栓塞治疗引起的肝疾病的预后因素和预防。
Hepatology. 2013 Mar;57(3):1078-87. doi: 10.1002/hep.26191. Epub 2013 Feb 15.